ArticleFrontiers in oncology2023

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.

Gloria Margiotta-Casaluci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.